http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1309321-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4951b3e7873cf96fd131185eb902b29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e0b60498ea409fcb02c3b800e29fda3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate | 2001-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7f5a28fe52d11d37b12c72c24488208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3adf19e71140e987ac358a6d547a78c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bced8f38e65782f10d3ecbc15483cae7 |
| publicationDate | 2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1309321-A1 |
| titleOfInvention | Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| abstract | The invention relates to a composition comprising an amino acid like structure carrying a sulfur moiety and a biologically acceptable carrier for inhibiting islet dysfunction and/or autoimmune disorders. The amino acid like structure carrying a sulfur moiety may be taurine, L-cysteine, L-methionine, or a combination of these. Conditions of islet dysfunction include insulitis, Type 1 diabetes (IDDM), Type 2 diabetes (NIDDM), mature onset diabetes of the young (MODY), and gestational diabetes. Autoimmune disorders include insulitis, Type 1 diabetes, rheumatoid arthritis, thyroiditis and pancreatitis. The composition can be prepared as a pharmaceutical, a nutraceutical, food supplement, maternal supplement, or infant formula to be administered to individuals having or at risk of developing a condition of islet dysfunction or an autoimmune disorder. The composition can act to inhibit islet dysfunction through exerting anti-apoptotic or immunomodulatory activity. Methods are provided for inhibiting islet dysfunction and/or autoimmune disorders by administering an amino acid like structure carrying a sulfur moiety to an individual. |
| priorityDate | 2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.